US-REGISTERED COMPANY
Mounjaro and tirzepatide often appear in the same search, but they are not interchangeable names for the same commercial product.
What is Mounjaro?
Mounjaro is the protected name of a regulated pharmaceutical product containing tirzepatide. It has defined formulation, manufacturing, labeling and regulatory documentation.
What is tirzepatide?
Tirzepatide is the name of the active molecule. Scientific literature studies its combined activity at GIP and GLP-1 receptors. The molecular name alone does not mean that a material is Mounjaro or that it shares the same formulation, regulatory status or bioequivalence.
Why is the distinction important?
An approved medicine and a laboratory research material must be clearly distinguished. Peptiva does not sell Mounjaro. The neutrally labeled GIP/GLP Dual Agonist is a separate material intended only for laboratory, analytical and in-vitro research.
What should researchers compare?
- molecular identity
- declared quantity
- batch-specific analytical documentation
- identity and purity methods
- physical form and storage conditions
Sources
FDA regulatory information and current labeling for tirzepatide-containing medicines.
RESEARCH USE ONLY: This educational content concerns laboratory and scientific research. Peptiva research materials are not medicines and are not intended for use in humans or animals.